Tate & Lyle PLC
LSE:TATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tate & Lyle PLC
LSE:TATE
|
UK |
|
LHN Ltd
SGX:41O
|
SG |
|
Oceania Healthcare Ltd
ASX:OCA
|
NZ |
|
Poste Italiane SpA
OTC:PITAF
|
IT |
|
RealReal Inc
NASDAQ:REAL
|
US |
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
IL |
Intrinsic Value
The intrinsic value for
Tate & Lyle PLC (TATE) under the Base Case is hidden
GBX.
Compared with the current market price of 491.4 GBX, the stock appears hidden
.
TATE looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether TATE usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Tate & Lyle PLC.
The intrinsic value for
Tate & Lyle PLC (TATE) under the Base Case is hidden GBX.
Compared with the current market price of 491.4 GBX, the stock appears hidden.